Basic Information
| LncRNA/CircRNA Name | ACVR2B-AS1 |
| Synonyms | NA |
| Region | GRCh38_3:38451027-38454820 |
| Ensemble | ENSG00000229589 |
| Refseq | NR_028389 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | liver cancer |
| ICD-0-3 | C22.0 |
| Methods | other |
| Sample | TCGA |
| Expression Pattern | up-regulated |
| Function Description | ACVR2B-AS1, whose expression is upregulated in liver cancer. Higher ACVR2B-AS1 expression is an independent adverse prognostic factor for overall survival (OS) and relapse-free survival (RFS) in liver cancer patients. |
| Pubmed ID | 31886217 |
| Year | 2019 |
| Title | Investigation of the Clinical Significance and Prognostic Value of the lncRNA ACVR2B-As1 in Liver Cancer |
External Links
| Links for ACVR2B-AS1 | GenBank HGNC NONCODE |
| Links for liver cancer | OMIM COSMIC |